What is the Real Endpoints Marketplace?

Efficient value-based contracting for medical benefit drugs

• Focus is on medical benefit drugs for orphan conditions
• Payments to payers are on top of existing payment relationships
• No disruption to provider contracts
• Financially transparent: 100% of contracted value-basedpayment goes to payer